Collins J, Holder GE, Herbert H, Adams GGW. Batten disease: features to facilitate early diagnosis. Br J Ophthamol. 2006. https://doi.org/10.1136/bjo.2006.bjsep06atag.
Nita DA, Mole SE, Minassian BA. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;18(S2):73–88.
Santavuori P. Neuronal ceroid-lipofuscinoses in childhood. Brain Dev. 1988;10(2):80–3.
Rider JA, Rider DL. Batten disease: past, present, and future. Am J Med Genet Suppl. 1988;5:21–6.
Johnson TB, Cain JT, White KA, Ramirez-Montealegre D, Pearce DA, Weimer JM. Therapeutic landscape for Batten disease: current treatments and future prospects. Nat Rev Neurol. 2019;15(3):161–78.
PubMed PubMed Central Google Scholar
Johnson TB, White KA, Brudvig JJ, Cain JT, Langin L, Pratt MA, et al. AAV9 gene therapy increases lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-batten disease. Mol Ther. 2021;29(1):162–75.
di Ronza A, Bajaj L, Sharma J, Sanagasetti D, Lotfi P, Adamski CJ, et al. CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis. Nat Cell Biol. 2018;20(12):1370–7.
PubMed PubMed Central Google Scholar
Lonka L, Aalto A, Kopra O, Kuronen M, Kokaia Z, Saarma M, Lehesjoki A-E, et al. The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy. BMC Neurosci. 2005. https://doi.org/10.1186/1471-2202-6-27.
PubMed PubMed Central Google Scholar
Pesaola F, Quassollo G, Venier AC, De Paul AL, Noher I, Bisbal M. The neuronal ceroid lipofuscinosis-related protein CLN8 regulates endo-lysosomal dynamics and dendritic morphology. Biol Cell. 2021;113:419.
Kuronen M, Lehesjoki AE, Jalanko A, Cooper JD, Kopra O. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice. Neurobiol Dis. 2012;47(3):444–57.
Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol. 2013. https://doi.org/10.1177/0883073813494268.
PubMed PubMed Central Google Scholar
Herva R, Tyynela J, Hirvasniemi A, Syrjakallio-Ylitalo M, Haltia M. Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis. Brain Pathol. 2000;10(2):215–22.
Hirvasniemi A, Lang H, Lehesjoki AE, Leisti J. Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J Med Genet. 1994;31(3):177–82.
PubMed PubMed Central Google Scholar
Henzi B, Bartholdi D, Wildbolz M, Kohler B, Bürki S, Perret E, et al. Northern epilepsy: not so northern anymore. Neuropediatrics. 2017;48(S 01):P36.
Sahin Y, Güngör O, Gormez Z, Demirci H, Ergüner B, Güngör G, et al. Exome sequencing identifies a novel homozygous CLN8 mutation in a Turkish family with Northern epilepsy. Acta Neurol Belg. 2017;117(1):159–67.
Badura-Stronka M, Winczewska-Wiktor A, Pietrzak A, Hirschfeld AS, Zemojtel T, Wołyńska K, et al. CLN8 mutations presenting with a phenotypic continuum of neuronal ceroid lipofuscinosis-literature review and case report. Genes. 2021;12(7):956.
PubMed PubMed Central Google Scholar
Reinhardt K, Grapp M, Schlachter K, Brück W, Gärtner J, Steinfeld R. Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis. Clin Genet. 2010;77(1):79–85.
Pesaola F, Kohan R, Cismondi IA, Guelbert N, Pons P, Oller-Ramirez AM, et al. Congenital CLN8 disease of neuronal ceroid lipofuscinosis: a novel phenotype. Rev Neurol. 2019;68(4):155–9.
Ranta S, Topcu M, Tegelberg S, Tan H, Ustubutun A, Saatci I, et al. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat. 2004;23(4):300–5.
Gao Z, Xie H, Jiang Q, Wu N, Chen X, Chen Q. Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants. BMC Med Genet. 2018;19(1):21.
PubMed PubMed Central Google Scholar
Alkhars FZ, Bo Ali AY, Almohanna MA, Almajhad NA. Neuronal ceroid lipofuscinoses type 8: expanding genotype/phenotype diversity-first report from Saudi Arabia. Neurosciences. 2020;25(1):65–9.
PubMed PubMed Central Google Scholar
Attarian H, Brandes J, Dafer R, Gerard E, Giesser B. Sex differences in the study of neurological illnesses. (1875–8584 (Electronic)).
Miller VM. Why are sex and gender important to basic physiology and translational and individualized medicine? (1522–1539 (Electronic)).
Piscopo PA-O, Bellenghi M, Manzini V, Crestini A, Pontecorvi G, Corbo M, et al. A sex perspective in neurodegenerative diseases: micrornas as possible peripheral biomarkers. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22094423.
PubMed PubMed Central Google Scholar
Golden LC, Voskuhl R. The importance of studying sex differences in disease: The example of multiple sclerosis. (1097–4547 (Electronic)).
Vegeto E, Villa A, Della Torre S, Crippa V, Rusmini P, Cristofani R, et al. The role of sex and sex hormones in neurodegenerative diseases. Endocr Rev. 2020;41(2):273–319.
Nielsen AK, Østergaard JR. Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience. Eur J Paediatr Neurol. 2013;17(3):265–8.
Cialone J, Adams H, Augustine EF, Marshall FJ, Kwon JM, Newhouse N, et al. Females experience a more severe disease course in Batten disease. J Inherit Metab Dis. 2012;35(3):549–55.
Kovács AD, Pearce DA. Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender. Dis Model Mech. 2015;8(4):351–61.
PubMed PubMed Central Google Scholar
Makoukji J, El-Sitt S, Makhoul NJ, Soueid J, Kadara H, Boustany R-M. Sex differences in gene expression with galactosylceramide treatment in Cln3Δex7/8 mice. PLoS ONE. 2020;15(10):e0239537.
PubMed PubMed Central Google Scholar
Poppens MJ, Cain JT, Johnson TB, White KA, Davis SS, Laufmann R, et al. Tracking sex-dependent differences in a mouse model of CLN6-Batten disease. Orphanet J Rare Dis. 2019;14(1):19.
PubMed PubMed Central Google Scholar
Guarneri R, Russo D, Cascio C, D’Agostino S, Galizzi G, Bigini P, et al. Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis. Brain Res. 2004;1014(1–2):209–20.
Bronson RT, Lake BD, Cook S, Taylor S, Davisson MT. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten’s disease). Ann Neurol. 1993;33(4):381–5.
Palmer DN, Martinus RD, Cooper SM, Midwinter GG, Reid JC, Jolly RD. Ovine Ceroid Lipofuscinosis: the major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence. J Biol Chem. 1989;264(10):5736–40.
Palmer DN, Fearnley IM, Walker JE, Hall NA, Lake BD, Wolfe LS, et al. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet. 1992;42(4):561–7.
Zhang S, Wu M, Peng C, Zhao G, Gu R. GFAP expression in injured astrocytes in rats. Exp Ther Med. 2017;14(3):1905–8.
PubMed PubMed Central Google Scholar
Zhang Z, Ma Z, Zou W, Guo H, Liu M, Ma Y, et al. The appropriate marker for astrocytes: comparing the distribution and expression of three astrocytic markers in different mouse cerebral regions. Biomed Res Int. 2019;2019:9605265.
PubMed PubMed Central Google Scholar
Seehafer SS, Pearce DA. You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol Aging. 2006;27(4):576–88.
Palmer DN. The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs). Biochim Biophys Acta. 2015;1852(10 pt B):2287–91.
Seehafer SS, Pearce DA. Spectral properties and mechanisms that underlie autofluorescent accumulations in Batten disease. Biochem Biophys Res Commun. 2009;382(2):247–51.
PubMed PubMed Central Google Scholar
Jalanko A, Braulke T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2009;1793(4):697–709.
Mannix R, Berglass J, Berkner J, Moleus P, Qiu J, Andrews N, et al. Chronic gliosis and behavioral deficits in mice following repetitive mild traumatic brain injury. J Neurosurg. 2014;121(6):1342–50.
PubMed PubMed Central Google Scholar
Chen H, Desai A, Kim HY. Repetitive closed-head impact model of engineered rotational acceleration induces long-term cognitive impairments with persistent astrogliosis and microgliosis in mice. J Neurotrauma. 2017;34(14):2291–302.
PubMed PubMed Central Google Scholar
Sakakibara Y, Sekiya M, Saito T, Saido TC, Iijima KM. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease. BMC Neurosci. 2019;20(1):13.
PubMed PubMed Central Google Scholar
Gardner E, Mole SE. The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses. Front Neurol. 2021;12:754045.
PubMed PubMed Central Google Scholar
Rashid K, Akhtar-Schaefer I, Langmann T. Microglia in Retinal Degeneration. Front Immunol. 2019;10:1975.
PubMed PubMed Central Google Scholar
Rathnasamy G, Foulds WS, Ling EA, Kaur C. Retinal microglia: a key player in healthy and diseased retina. Prog Neurobiol. 2019;173:18–40.
Pontikis CC, Cella CV, Parihar N, Lim MJ, Chakrabarti S, Mitchison HM, et al. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Res. 2004;1023(2):231–42.
Mirza M, Volz C, Karlstetter M, Langiu M, Somogyi A, Ruonala MO, et al. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PLoS ONE. 2013;8(10):e75963.
留言 (0)